News1 July 2026
SCAN 2025: a New Zealand reading
Our SCAN 2025 results are in. 110 patients and 73 clinicians told us where New Zealand leads on NET care – and where we still fall short.
New Zealanders with NETs rarely pay for their care, and access to treatments like PRRT is now among the best in the world. But they still wait longer, and remain largely cut off from the trials and newer medicines others reach. 110 patients and 73 clinicians told us where we lead – and where we still fall short.
- 91% say PRRT is provided free here, against 40% globally.
- 50% saw a NET nurse specialist (28% globally). Care is nurse-led, and it’s free.
- 59% report treatment delays (33% globally); only 37% have heard of NET trials (57% globally).
